Heteronemin alone significantly inhibited PCNA expression in both cell lines, and the combination of heteronemin and tetrac also showed a significant reduction in PCNA mRNA in HCT-116 cells (KRAS MT CRC). This evidence concerns the gene KRAS and colorectal carcinoma.